Skip to content

Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors

Diagnostic Relevance of Laser Confocal Microscopy During Reno-ureteroscopy in the Context of the Screening and Follow-up of Upper Urinary Tract Tumors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02276924
Acronym
UROVISIO
Enrollment
29
Registered
2014-10-28
Start date
2013-10-31
Completion date
2016-10-31
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Urinary Tract, Hematuria, Nephrolithiasis, Ureteropelvic Junction Obstruction

Keywords

Laser Confocal Microscopy, Superior Urinary Tract Tumors

Brief summary

Upper Urinary Tract Tumors have an incidence of 1 to 2 cases for 100 000 persons per year. The standard treatment for these tumors is the ablation of the kidney, ureter and a part of the bladder surrounding the ureteral orifice. The development of new diagnosis and treatment techniques through natural routes opens the possibility to use conservative treatments. The investigators hypothesis is that during a reno-ureteroscopy, laser confocal microscopy will allow the discrimination between normal and pathologic urothelium by microscopic analysis. This will prevent the systematic use of biopsies which are often difficult and iatrogenic.

Detailed description

The objective of the present study is to assess contribution of laser confocal microscopy in diagnosing of upper urinary tract tumors during a reno-uteroscopy compared to analysing of architectural elements (vascular characteristics, organization) and cellular (morphology, cohesion, border).

Interventions

DEVICELaser confocal microscopy

Patients undergoing a reno-ureteroscopy for diagnosis or treatment indication will receive an intra-vesical instillation of fluorescein (0.1%) for 5 minutes, followed by the laser confocal microscopy procedure.

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any legally adult fully informed patient who consent to participate to the study * Patient followed by the Urology Department * Indication for a diagnosis or treatment reno-ureteroscopy * Coverage of the social insurance

Exclusion criteria

* Minor Patient * Pregnancy or breast feeding * Concomitant treatment (for example beta-blocker) * Contra-indication to general anaesthesia * Hypersensitivity to sodium fluorescein * Medical history of cardio-pulmonary disease (myocardial infarction, cardiovascular event, bronchospasm ...) due to fluorescein instillation * Medical history of asthma or allergy due to fluorescein instillation

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic relevance of laser confocal microscopy compared to the cytological and histological data, during reno-ureteroscopy according to Chang's reference criteria24 monthsAccording to Chang's reference criteria, we will define the urothelial microarchitecture (normal, papillary, inflammatory, low grade lesion, high grade lesion, in situ carcinoma). The diagnostic relevance of the MCL (absence or presence of the lesion) will be compare to the reference tests calculating sensibility, specificity and predictive values

Secondary

MeasureTime frameDescription
Inter- and intra-observer diagnostic concordance24 monthsAnonymized videos of the intervention will be reviewed at the end of the study by a naive surgeon to assess inter-observer concordance. A concordance Kappa test will be performed
Surgery duration24 months
Reference atlas24 monthsVideos and images quality will be assessed to compile them in a refence atlas

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026